Fibrinogen Antikörper

Details for Product anti-Fibrinogen Antibody No. ABIN673854, Anbieter: Anmelden zum Anzeigen
Antigen
  • fib2
  • MGC53620
  • fibrinogen
  • sb:cb892
  • wu:fa55c12
  • wu:fb20e08
  • wu:fb59b03
  • wu:fi39d04
  • zgc:92117
  • fibrinogen alpha chain
  • fibrinogen gamma chain
  • fga
  • FGA
  • CpipJ_CPIJ010090
  • FGG
Reaktivität
Human
314
86
56
33
28
24
14
4
1
1
1
Wirt
Kaninchen
158
157
129
62
9
3
Klonalität
Polyklonal
Konjugat
Dieser Fibrinogen Antikörper ist unkonjugiert
46
46
45
7
6
6
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
Applikation
ELISA
331
257
54
54
52
42
40
38
35
33
28
26
20
19
15
9
8
6
4
3
2
2
2
1
1
1
1
1
1
1
1
1
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
'Independent Validation' Siegel
Chargennummer 980680
Validierte Anwendung ELISA
Positivkontrolle Liver
Negativkontrolle Skeletal muscle
Bewertung Signal was detected in positive control samples but not in negative control samples.
Primärantikörper
  • Antibody: Fibrinogen antibody
  • Catalog number: ABIN673854
  • Batch number: 980680
Kontrollen
  • Positive control: protein extract from human liver (specimen known to contain the target protein) was from Alamo Laboratories, Inc (Cat # 2001-TEL-Hu).
  • Negative control: protein extract from mouse skeletal muscle (specimen known to not contain the target protein) was from Alamo Laboratories, Inc (Cat # 2002-TEM-Mm).
  • Standard curve: serial two-fold dilutions from 200 ng/ml [200, 100, 50, 25, 12.5, 6.25, 3.125, 1.5625, 0.78125, 0] were generated from Fibrinogen peptide stock diluted in 1 x 50 mM Carbonate buffer, pH 9.5.
  • Spike control: standard diluted in protein lysate buffer [25 and 0].
Protokoll
  • A 96-well MICROLON® 600 96W High Binding 12 x 8 Clear Strip Microplate was coated with antigen by pipetting 100 µL of sample per well. All samples and standards were assayed in triplicate.
  • The microplate was covered and incubated at 25°C overnight.
  • After overnight coating, plate contents were discarded and wells were washed 3 times with 150 µL of 1 x PBST (PBS, 0.1% Tween-20) per well.
  • Wells were then blocked with 250 µL of 1 x PBS / 0.05% Tween-20 / 1% BSA per well and incubated at 37°C for 2 h.
  • After blocking, plate contents were discarded and wells were washed 3 times with 250 µL of 1 x PBS per well.
  • 100 µL of primary antibody diluted 1:500 in 1 x PBS / 0.05% Tween-20 / 1% BSA was added per well and incubated at 37°C for 2 h.
  • Plate contents were discarded and wells were washed 3 times with 200 µL of 1 x PBST per well.
  • 100 µL of HRP conjugated secondary antibody diluted 1:10000 in 1 x PBS / 0.05% Tween-20 / 1% BSA was added per well and incubated at 37°C for 1 h.
  • Plate contents were discarded and wells were washed 3 times with 200 µL of 1 x PBST per well.
  • 100 µL of TMB (3,3', 5,5"-tetramethylbenzidine) substrate was added per well and incubated at 37°C for 10 min.
  • 100 µL of STOP solution was added per well.
  • The optical density (OD value) of each well was read using a microplate reader set to 450 nm.
  • The triplicate readings for each sample were averaged and the average zero standard optical density subtracted. The corrected average-value was tabulated as Average Absorbance. A standard curve was generated by plotting the mean OD value for each standard on the y-axis against the concentration on the x-axis using Excel. A line of best fit through the points on the graph was used to generate the equation X = (Y-0.0122) / 0.0113.
  • The equation X = (Y-0.0122) / 0.0113 was used to calculate fibrinogen concentrations of the samples based on their Average Absorbance values.
Anmerkungen None
Validierungsbilder
ELISA validation image for anti-Fibrinogen antibody (ABIN673854) Figure 1: Graph of corrected-average absorbance (OD 450 nm) readings plotted for stan...
ELISA validation image for anti-Fibrinogen antibody (ABIN673854) Table 1: ELISA. Fibrinogen is present in the positive control sample (liver) and abse...
Immunogen Fibrinogen from human plasma
Isotyp IgG
Reinigung Purified by Protein A.
Andere Bezeichnung Human Fibrinogen
Hintergrund

Cleaved by the protease thrombin to yield monomers which, together with fibrinogen beta (FGB) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using anticoagulated blood. However, subsequent studies have shown that it is not absolutely required for thrombus formation in vivo. Enhances expression of SELP in activated platelets via an ITGB3-dependent pathway. Maternal fibrinogen is essential for successful pregnancy. Fibrin deposition is also associated with infection, where it protects against IFNG-mediated hemorrhage. May also facilitate the immune response via both innate and T-cell mediated pathways.

Synonyms: Fib2, Fibrinogen alpha chain, FGA

Gen-ID 2243
UniProt P02671
Applikationshinweise ELISA 1:500-1000
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Konservierungsmittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Lagerung -20 °C
Informationen zur Lagerung Store at -20°C
Haltbarkeit 12 months
Bilder des Herstellers
ELISA image for anti-Fibrinogen antibody (ABIN673854) Antigen: human liver Primary:Rabbit Anti-human Fibrinogen Polyclonal Antibody, 1:500 ...
Produkt verwendet in: Chen, Yang, Liao, Wang, Chen, Sun, Huang: "Effect of the duration of UV irradiation on the anticoagulant properties of titanium dioxide films." in: ACS applied materials & interfaces, Vol. 7, Issue 7, pp. 4423-32, 2015 (PubMed).

Chen, Zhao, Chen, Liao, Yang, Sun, Huang: "The effect of full/partial UV-irradiation of TiO2 films on altering the behavior of fibrinogen and platelets." in: Colloids and surfaces. B, Biointerfaces, Vol. 122, pp. 709-18, 2014 (PubMed).

Haben Sie etwas anderes gesucht?